The company’s board is asking shareholders to support two corporate-governance proposals, including one that would eliminate a requirement that buyout bids garner at least 80 percent shareholder approval.
FDA Commissioner Scott Gottlieb aimed particular criticism at giant pharmacy benefit managers that contract with health plans to administer coverage of drugs, saying the industry’s tactics have stymied cheaper copies of expensive biotechnology drugs.
Eli Lilly CEO David Ricks’ first year in charge was marked by a wave of activity, including a huge corporate restructuring. The company’s stock price climbed about 6.2 percent during the year.
American Pain Consortium Holdings LLC, led by Dr. Edward J. Kowlowitz, plans to operate 15 to 20 pain-management practices within three years.
The state’s largest health care system saw gains in admissions, inpatient days and surgeries, but visits to the ER and radiology exams dropped slightly.
Even before news broke that an unidentified health care system had lined up 30 acres at 96th Street and Spring Mill Road for a massive development, projects costing billions of dollars were underway or on the drawing board across the region.
Hospital systems have been opening urgent-care centers at a fast clip, using the small storefront locations to expand revenue, reduce demand on their emergency rooms, and get patients into their networks.
The Indianapolis-based drugmaker said the medicine, called Taltz, proved effective for treating a type of back stiffness, and hopes to submit it for government approval this year.
The fast-growing health system, owned by Hamilton County, plans to begin construction this year and open the centers in Carmel, Fishers and Indianapolis in 2019.
As a candidate, President Trump advocated Medicare negotiations and allowing consumers to import medicines from abroad. His current strategy recommends changes to policies that the administration believes unwittingly lead to higher prices, and suggests ways to speed drugs to market and increase competition.
Since October, when Eli Lilly and Co. announced it was reviewing whether to sell or spin off Elanco, Greenfield city leaders have been wondering what the future holds for the city’s economy.
Express Scripts Holding Co., one of the biggest pharmacy-benefits managers, says the drug-price deals it cuts behind closed doors are saving consumers a lot of money.
Greenlight Guru grew from 19 to 31 employees in the last year and expects to add nine more during the first quarter of this year.
News on Tuesday that Amazon was forming a new company with JPMorgan Chase and Warren Buffett’s big-pocketed Berkshire Hathaway sent shock waves through the health care industry.
Lawmakers stripped a provision from the bill that would have boosted the cigarette tax from 99 cents a pack to $2.99.
Several major not-for-profit hospital groups, including the parent of St. Vincent Health in Indianapolis, are trying their own solution to drug shortages and high prices.
Hancock Health in Greenfield says it has been able to recover the use of its computers and that no patient information was adversely affected.
Methodist Sports Medicine, a private chain of orthopedic and sports clinics in central Indiana, is expanding into southern Indiana with the acquisition of Bloomington Bone & Joint Clinic.
Alex Azar, a former Eli Lilly and Co. executive, acknowledged to the Senate Finance Committee that drug prices are too high and said he'd work to lower them if confirmed as secretary of Health and Human Services.
Eli Lilly and Co. CEO Dave Ricks said Monday that the recent changes in U.S. tax policy will help the drugmaker lower its global tax burden as he continues to look for deals in areas like oncology.
